Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Over the last 12 months, insiders at Acumen Pharmaceuticals, Inc. have bought $40M and sold $394,011 worth of Acumen Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Acumen Pharmaceuticals, Inc. have bought $49.68M and sold $394,011 worth of stock each year.
Highest buying activity among insiders over the last 12 months: RA CAPITAL MANAGEMENT, L.P. () — $1,000M.
The last purchase of 5,161,290 shares for transaction amount of $40M was made by RA CAPITAL MANAGEMENT, L.P. () on 2023‑07‑21.
2024-01-19 | Sale | OConnell Daniel Joseph | President and CEO | 15,200 0.0253% | $3.47 | $52,753 | -6.50% | |
2024-01-19 | Sale | Meisner Derek M | Chief Legal Officer & Corp Sec | 8,933 0.0149% | $3.48 | $31,048 | -6.50% | |
2024-01-18 | Sale | Zuga Matt | CFO & Chief Business Officer | 4,242 0.0075% | $3.71 | $15,717 | -7.25% | |
2024-01-18 | Sale | Siemers Eric | Chief Medical Officer | 3,124 0.0055% | $3.71 | $11,604 | -7.25% | |
2024-01-18 | Sale | Barton Russell | Chief Operating Officer | 2,833 0.005% | $3.73 | $10,555 | -7.25% | |
2023-08-17 | Sale | Ives Jeffrey L. | director | 41,949 0.0739% | $6.49 | $272,334 | -45.31% | |
2023-07-21 | RA CAPITAL MANAGEMENT, L.P. | 5.16M 13.1759% | $7.75 | $40M | -51.11% | |||
2021-07-06 | RA CAPITAL MANAGEMENT, L.P. | 1.88M 3.8811% | $16.00 | $30M | -67.95% | |||
2021-07-06 | Hardie Robert D. | 10 percent owner | 1.06M 2.1993% | $16.00 | $17M | -67.95% | ||
2021-07-06 | Sands Capital Ventures Discovery Fund III, L.P. | 10 percent owner | 450,000 0.8663% | $14.88 | $6.7M | -67.95% | ||
2021-07-06 | Manning Paul B | 10 percent owner | 312,500 0.6468% | $16.00 | $5M | -67.95% | ||
2021-07-06 | Stalfort John A III | director | 35,000 0.0724% | $16.00 | $560,000 | -67.95% | ||
2021-07-06 | Fountain Nathan B | director | 6,250 0.0129% | $16.00 | $100,000 | -67.95% |
RA CAPITAL MANAGEMENT, L.P. | 13043179 22.523% | $2.16 | 2 | 0 | <0.0001% | |
OConnell Daniel Joseph | President and CEO | 502485 0.8677% | $2.16 | 0 | 1 | |
Zuga Matt | CFO & Chief Business Officer | 211445 0.3651% | $2.16 | 0 | 1 | |
Siemers Eric | Chief Medical Officer | 117576 0.203% | $2.16 | 0 | 1 | |
Meisner Derek M | Chief Legal Officer & Corp Sec | 108867 0.188% | $2.16 | 0 | 1 | |
Barton Russell | Chief Operating Officer | 96867 0.1673% | $2.16 | 0 | 1 | |
Ives Jeffrey L. | director | 0 0% | $2.16 | 0 | 1 | |
Hardie Robert D. | 10 percent owner | 3951156 6.8229% | $2.16 | 1 | 0 | <0.0001% |
Sands Capital Ventures Discovery Fund III, L.P. | 10 percent owner | 3417075 5.9006% | $2.16 | 1 | 0 | <0.0001% |
Manning Paul B | 10 percent owner | 3352693 5.7894% | $2.16 | 1 | 0 | <0.0001% |
Stalfort John A III | director | 172324 0.2976% | $2.16 | 1 | 0 | <0.0001% |
Fountain Nathan B | director | 6250 0.0108% | $2.16 | 1 | 0 | <0.0001% |
RA Capital Management, L.P. | $60.47M | 24.85 | 14.93M | 0% | +$0 | 0.06 | |
Sands Capital Ventures LLC | $13.84M | 5.69 | 3.42M | 0% | +$0 | 3.34 | |
Franklin Templeton Investments | $13.75M | 5.65 | 3.4M | +1.09% | +$148,266.45 | <0.01 | |
Millennium Management LLC | $10.65M | 4.38 | 2.63M | +75.86% | +$4.59M | 0.01 | |
ROCK SPRINGS CAPITAL MANAGEMENT, LP | $9.32M | 3.83 | 2.3M | 0% | +$0 | 0.24 | |
Fidelity Investments | $8.46M | 3.48 | 2.09M | New | +$8.46M | <0.01 | |
Laurion Capital Management LP | $7.67M | 3.15 | 1.9M | 0% | +$0 | 0.21 | |
The Vanguard Group | $6.74M | 2.77 | 1.67M | -9.49% | -$706,700.71 | <0.0001 | |
T. Rowe Price | $4.45M | 1.83 | 1.1M | New | +$4.45M | <0.01 | |
Alyeska Investment Group L P | $3.81M | 1.56 | 939,603 | +28.15% | +$835,919.97 | 0.02 | |
Jane Street Capital | $2.43M | 1 | 600,255 | -0.72% | -$17,678.25 | <0.01 | |
Parkman Healthcare Partners Llc | $2.34M | 0.96 | 576,657 | -4.45% | -$108,702.01 | 0.29 | |
Hudson Bay Capital Management LP | $2.27M | 0.93 | 560,000 | -0.78% | -$17,820.00 | 0.02 | |
Schonfeld Group | $1.86M | 0.76 | 458,484 | -18.35% | -$417,384.63 | 0.01 | |
Goldman Sachs | $1.29M | 0.53 | 317,904 | +177.08% | +$822,846.47 | <0.0001 | |
Geode Capital Management | $1.16M | 0.48 | 285,139 | +7.76% | +$83,190.82 | <0.0001 | |
Ikarian Capital LLC | $1.08M | 0.44 | 266,435 | -15.49% | -$197,761.73 | 0.31 | |
Susquehanna International Group | $1.08M | 0.44 | 265,843 | -46.81% | -$947,501.42 | <0.01 | |
Tang Capital Management, LLC | $999,925.00 | 0.41 | 246,895 | 0% | +$0 | <0.01 | |
Two Sigma Advisers LP | $878,850.00 | 0.36 | 217,000 | +67.31% | +$353,565.00 | <0.01 | |
BlackRock | $768,273.00 | 0.32 | 189,697 | -23.54% | -$236,511.95 | <0.0001 | |
Man Group Plc | $759,719.00 | 0.31 | 187,585 | +29.7% | +$173,967.69 | <0.01 | |
Two Sigma | $720,499.00 | 0.3 | 177,901 | -27.21% | -$269,385.73 | <0.01 | |
Qube Research & Technologies | $678,731.00 | 0.28 | 167,588 | +89.1% | +$319,795.91 | <0.01 | |
Td Asset Management Inc | $602,640.00 | 0.25 | 148,800 | New | +$602,640.00 | <0.01 | |
Bridgeway Capital Management | $601,020.00 | 0.25 | 148,400 | New | +$601,020.00 | 0.01 | |
Citigroup | $548,346.00 | 0.23 | 135,394 | -8.4% | -$50,288.88 | <0.0001 | |
Squarepoint Ops LLC | $458,590.00 | 0.19 | 113,232 | +114.34% | +$244,632.36 | <0.01 | |
Wellington Management Company | $454,645.00 | 0.19 | 112,258 | New | +$454,645.00 | <0.0001 | |
Hrt Financial Llc | $425,000.00 | 0.18 | 105,117 | New | +$425,000.00 | <0.01 | |
New York Life Investment Management Llc | $385,110.00 | 0.16 | 95,089 | New | +$385,110.00 | <0.01 | |
Marshall Wace | $363,314.00 | 0.15 | 89,707 | New | +$363,314.00 | <0.0001 | |
Catalyst Financial Partners Llc | $311,256.00 | 0.15 | 89,699 | 0% | +$0 | 0.08 | |
State Street | $331,201.00 | 0.14 | 81,778 | -3.88% | -$13,365.00 | <0.0001 | |
Bank of America | $326,495.00 | 0.13 | 80,616 | -22.76% | -$96,199.71 | <0.0001 | |
JPMorgan Chase | $291,155.00 | 0.12 | 71,890 | +111.78% | +$153,677.51 | <0.0001 | |
Balyasny Asset Management Llc | $258,993.00 | 0.11 | 63,949 | +210.76% | +$175,652.24 | <0.01 | |
Susquehanna Fundamental Investments Llc | $253,198.00 | 0.1 | 62,518 | New | +$253,198.00 | 0.01 | |
Dimensional Fund Advisors | $249,999.00 | 0.1 | 61,728 | +10.64% | +$24,044.91 | <0.0001 | |
The Manufacturers Life Insurance Company | $243,166.00 | 0.1 | 60,041 | New | +$243,166.00 | <0.0001 | |
Marathon Trading Investment Management Llc | $243,000.00 | 0.1 | 60,000 | New | +$243,000.00 | 0.1 | |
Brevan Howard Capital Management Lp | $228,294.00 | 0.09 | 56,369 | New | +$228,294.00 | 0.02 | |
Northern Trust | $229,931.00 | 0.09 | 56,773 | +0.17% | +$384.75 | <0.0001 | |
Boothbay Fund Management LLC | $209,417.00 | 0.09 | 51,708 | -37.08% | -$123,419.46 | 0.01 | |
Morgan Stanley | $197,284.00 | 0.08 | 48,712 | +110.64% | +$103,623.51 | <0.0001 | |
Barclays | $191,000.00 | 0.08 | 47,310 | -0.08% | -$149.38 | <0.0001 | |
Prelude Capital | $149,850.00 | 0.06 | 37,000 | +27.15% | +$31,995.00 | 0.01 | |
Y Intercept Hong Kong Ltd | $150,624.00 | 0.06 | 37,191 | +92.22% | +$72,264.37 | 0.01 | |
American Century Investments | $140,146.00 | 0.06 | 34,604 | +39.94% | +$39,997.74 | <0.0001 | |
Bank of Montreal | $131,747.00 | 0.05 | 31,900 | New | +$131,747.00 | <0.0001 |